⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Securities Lawsuit Alert: ARS Pharmaceuticals, Inc. (SPRY) Investors - Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY
Kaplan Fox Alerts ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors Who Suffered Losses to a Securities Class Action – Deadline is October 5, 2026
globenewswire.com
SPRY
Securities Lawsuit Alert: ARS Pharmaceuticals, Inc. (SPRY) Investors - Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY
Pomerantz LLP Updates Shareholders on Legal Action Brought Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Join Class Action to Recover Losses from ARS Pharmaceuticals, Inc. (SPRY) - Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY
Shareholders of ARS Pharmaceuticals, Inc. (SPRY): Protect Your Rights Before October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY
SPRY IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 5 Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Class Action Alert: Levi & Korsinsky Reminds ARS Pharmaceuticals (SPRY) Investors of October 5, 2026 Deadline
accessnewswire.com
SPRY
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - SPRY
prnewswire.com
SPRY
Kaplan Fox Notifies ARS Pharmaceuticals Inc. (SPRY) Investors of a Securities Class Action Lawsuit - Deadline is October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY